Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gram-negative Bacteremia”

57 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 57 results

Not applicableStudy completedNCT04821661
What this trial is testing

T2 and SeptiCyte RAPID Duration Project

Who this might be right for
Bacteremia
The University of Queensland 102
Post-approval studies (Phase 4)Study completedNCT00609375
What this trial is testing

Efficacy of Cefepime Continuous Infusion Versus an Intermittent Dosing Regimen

Who this might be right for
SepsisBacteremia
Javeriana University 30
Not applicableStudy completedNCT03889067
What this trial is testing

Understanding How Salmonella Typhi Infects Humans (Bottlenecks)

Who this might be right for
Salmonella Typhi Infection
University of Oxford 11
Not applicableNo Longer AvailableNCT04636554
What this trial is testing

Personalized Phage Treatment in Covid-19 Patients With Bacterial Co-Infections Microbials for Pneumonia or Bacteremia/Septicemia

Who this might be right for
Covid19BacteremiaSepticemia+3 more
Adaptive Phage Therapeutics, Inc.
Post-approval studies (Phase 4)Study completedNCT00406198
What this trial is testing

Impact of Continuous Venovenous Haemofiltration on Organ Failure During the Early Phase of Severe Sepsis

Who this might be right for
BacteremiaGram-Negative Bacterial InfectionsGram-Positive Bacterial Infections+3 more
Hopital Lariboisière 400
Not applicableStudy completedNCT02573064
What this trial is testing

Impact of Treatment With Colistin on Mortality Bacteremia Multiresistant Acinetobacter Baumannii Sensitive Colistin in Patients Critical

Who this might be right for
Acinetobacter Infections
Maimónides Biomedical Research Institute of Córdoba 113
Not applicableStudy completedNCT02599220
What this trial is testing

Clinical Outcomes and Cost of Gram Negative Bacteremia

Who this might be right for
Gram-negative BacteremiaBacteremia
Duke University 2,000
Not applicableStudy completedNCT03218397
What this trial is testing

Rapid Identification and Phenotypic Susceptibility Testing for Gram-Negative Bacteremia

Who this might be right for
Gram-negative Bacteremia
Duke University 500
Large-scale testing (Phase 3)Study completedNCT02400268
What this trial is testing

Antibiotic Treatment Duration (7 vs 14 Days) Comparison in Blood Stream Infection Causes by Enterobacteriaceae

Who this might be right for
Enterobacteriaceae InfectionsBloodstream Infection
Fundación Pública Andaluza para la gestión de la Investigación en Sevilla 238
Post-approval studies (Phase 4)Ended earlyNCT04673175
What this trial is testing

Ceftolozane-Tazobactam for Directed Treatment of Pseudomonas Aeruginosa Bacteremia and Pneumonia in Patients With Hematological Malignancies and Hematopoietic Stem Cell Transplantation

Who this might be right for
PneumoniaHematologic MalignancyPseudomonas Aeruginosa Infection+2 more
Weill Medical College of Cornell University 17
Not applicableLooking for participantsNCT06966284
What this trial is testing

A Post-Marketing Study to Assess the Efficacy and Safety of Intravenous Polymyxin B and Colistin Methanesulfonate in Patients With Carbapenem-Resistant Gram-Negative Bacterial Infection

Who this might be right for
Bacteremia Caused by Gram-Negative BacteriaBacterial Pneumonia
TTY Biopharm 480
Not applicableLooking for participantsNCT07372131
What this trial is testing

Antibiotic Duration and Outcomes in High-Risk Febrile Neutropenia Patients

Who this might be right for
Bloodstream InfectionGram Negative InfectionsBacteraemia Caused by Gram-Negative Bacteria+1 more
Humanitas University 172
Not applicableUnknownNCT04903886
What this trial is testing

Intensive Care Unit Acquired Infections in Patients Colonized With Extended Spectrum Enterobacteriaceae

Who this might be right for
Ventilator Associated PneumoniaBacteremiaAbdominal Infection+1 more
University Hospital, Brest 350
Not applicableStudy completedNCT06174649
What this trial is testing

Fast Antibiotic Susceptibility Testing for Gram Negative Bacteremia Trial

Who this might be right for
Gram-negative BacteremiaBloodstream Infection
Duke University 900
Large-scale testing (Phase 3)Study completedNCT02447432
What this trial is testing

Compare the Immunogenicity of GSK Biologicals' 10Pn-PD-DiT 4-dose Presentation to the Licensed 1-dose Synflorix™ (10Pn-PD-DiT) Vaccine When Co-administered With DTPw-combination Vaccine in Healthy Infants

Who this might be right for
Infections, Streptococcal
GlaxoSmithKline 320
Not applicableStudy completedNCT02257931
What this trial is testing

Gram-negative Bacteremia in HSCT Recipients

Who this might be right for
Allogeneic or Autologous HSCT
European Society for Blood and Marrow Transplantation 591
Not applicableLooking for participantsNCT02979951
What this trial is testing

Fosfomycin I.v. for Treatment of Severely Infected Patients

Who this might be right for
Bacterial InfectionsBone Diseases, InfectiousOsteomyelitis+13 more
Infectopharm Arzneimittel GmbH 1,000
Not applicableEnded earlyNCT05210387
What this trial is testing

Seven Versus 14 Days of Antibiotic Therapy for Multidrug-resistant Gram-negative Bacilli Infections

Who this might be right for
Carbapenem-Resistant Enterobacteriaceae InfectionBloodstream InfectionSevere Infection+7 more
Hospital Moinhos de Vento 107
Not applicableStudy completedNCT04146922
What this trial is testing

Switch to Oral Antibiotics in Gram-negative Bacteremia

Who this might be right for
Escherichia Coli BacteremiaKlebsiella BacteraemiaEnterobacter Bacteraemia+3 more
Hamad Medical Corporation 176
Not applicableStudy completedNCT05741424
What this trial is testing

Impact of BacT/Alert® VIRTUO®, BioFire® Blood Culture Identification 2-BCID2 and REVEAL® (bioMérieux) on the Optimization of Antibiotic Therapy for Gram-negative Bacteremia in the ICU

Who this might be right for
Bacteremia
Centre Hospitalier Universitaire de Nīmes 100
Load More Results